CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities
Net earnings	$ 17,853	$ 21,504
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	2,028	2,146
Amortization	376	397
Deferred taxes	(1,157)	(3,742)
Premium amortization, net of discount accretion	1,240	2,914
Net realized loss on sales of securities available for sale	229	0
Gain on sale of loans	(787)	(1,787)
Reversal of provision for credit losses	0	(1,250)
Origination of loans held for sale	(22,127)	(48,365)
Proceeds from loans held for sale	25,275	51,511
Net gain on sale of premises, equipment, other real estate owned and other assets	(2,945)	(38)
Stock based compensation	298	321
Net change in accrued interest receivable and other assets	(982)	(1,983)
Net change in accrued interest payable and other liabilities	2,251	1,067
Net cash provided by operating activities	21,552	22,695
Securities available for sale:
Purchases	(484,132)	(17,201)
Proceeds from Sales	21,268	0
Proceeds from maturities and principal repayments	482,114	24,465
Securities held to maturity:
Purchases	0	(1,033,052)
Proceeds from maturities and principal repayments	70,637	607,338
Net originations of loans	43,363	(230,359)
Purchases of premises and equipment	(3,888)	(2,882)
Proceeds from sale of premises, equipment, other real estate owned and other assets	3,492	77
Net cash provided by (used in) investing activities	132,854	(651,614)
Cash flows from financing activities
Net change in deposits	(78,337)	109,131
Net change in securities sold under agreements to repurchase	13,311	(6,280)
Proceeds from FHLB advances	1,725,000	124,000
Repayment of FHLB advances	(1,820,000)	(40,000)
Proceeds from line of credit	12,000	1,000
Repayment of line of credit	0	(6,000)
Proceeds from issuance of subordinated debt	0	34,336
Repayments of debentures	(1,500)	(3,093)
Purchase of treasury stock	(8,850)	(8,151)
Exercise of stock options	225	474
Cash dividends paid	(5,371)	(5,080)
Net cash (used in) provided by financing activities	(163,522)	200,337
Net change in cash and cash equivalents	(9,116)	(428,582)
Cash and cash equivalents at beginning of period	106,467	499,605
Cash and cash equivalents at end of period	97,351	71,023
Supplemental disclosures of cash flow information
Interest paid	24,150	3,312
Income taxes paid	4,080	4,400
Supplemental schedule of noncash investing and financing activities
Cash dividends accrued	2,668	2,623
Lease right of use assets obtained in exchange for lease liabilities	568	337
Available for sale securities transferred to held to maturity, net of unrealized loss of $13,186	0	106,157
Transfer of loans to other real estate owned and repossessed assets	0	27
Contributions from noncontrolling interest	$ 0	$ 580